Glycomimetics earnings were -$37.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest GLYC earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$7.2M, down 26.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GLYC reported annual earnings of -$37.9M, with 2.7% growth. The next GLYC earnings date is May 7, 2025.
On GLYC's earnings call on Invalid Date, Glycomimetics (NASDAQ: GLYC) reported Q4 2024 earnings per share (EPS) of -$0.11, up 21.43% year over year. Total GLYC earnings for the quarter were -$7.22 million. In the same quarter last year, Glycomimetics's earnings per share (EPS) was -$0.14.
The next GLYC earnings call is Invalid Date. Add GLYC to your watchlist to be reminded of Glycomimetics's next earnings date.
What was GLYC's earnings growth in the past year?
As of Glycomimetics's earnings date in Invalid Date, Glycomimetics's earnings has grown year over year. GLYC earnings in the past year totalled -$37.88 million.
Is Glycomimetics profitable or losing money?
As of the last Glycomimetics earnings report, Glycomimetics is currently losing money. Glycomimetics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$37.88 million, a 2.66% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.